達安基因(002030.SZ)大幅上修業績預告:半年度淨利潤預增924.57%-1222.03%
格隆匯 7 月 13日丨達安基因(002030.SZ)發佈2020年半年度業績預告修正公告,之前在2020年第一季度報告中披露,預計2020年1-6月歸屬於上市公司股東的淨利潤變動幅度為400%至643.64%,2020年1-6月歸屬於上市公司股東的淨利潤變動區間為30256.6萬元至45000萬元。
修正後,預計2020年半年度歸屬於上市公司股東的淨利潤6.2億元-8億元,同比增長924.57%-1222.03%。
受新型冠狀病毒肺炎疫情影響,市場對新型冠狀病毒(2019-nCoV)核酸檢測試劑盒及核酸檢測儀器、相關耗材的需求量大幅度增長,對公司業績產生了積極影響。疫情發展情況對前期業績預計準確性存在不確定影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.